Publications | CESAR l Center for Substance Abuse Research l University of Maryland

DEA Emerging Threat Report: Third Quarter 2019Drug Enforcement Administration (DEA) Special Testing and Research Laboratory DEA-Emerging-Threat-Report-2019-Quarter-3.pdf693.07 KB
The Co-Use of Methamphetamine and Opioids Among Patients in Treatment in Oregon, USA; Andrea M. Lopez, Ph.D., Department of Anthropology, University of Maryland, College ParkThe National Drug Early Warning System Coordinating Center, Center for Substance Abuse Research, University of Maryland, College Park NDEWS-Hotspot-Serenity-Lane-Sept2019-FINAL.pdf615.2 KB
Cao, Y., Stewart, K., Wish, E., Artigiani, E., Sorg, M. (2019). Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire. Journal of Substance Abuse Treatment.
DEA Emerging Threat Report: Mid Year 2019Drug Enforcement Administration (DEA) Special Testing and Research Laboratory
DEA Emerging Threat Report: Second Quarter 2019Drug Enforcement Administration (DEA) Special Testing and Research Laboratory
A Pilot Study Using Electronic Health Records from Hospital Emergency Departments to Monitor Drug Use Trends in Overdose Patients in the Baltimore Area, January 2016-December 2018Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, BSN, Ebonie Massey, MA, & E. Erin Artigiani, MA EDDS-EHR-MD-Baltimore-Report-2016-2018.pdf1.9 MB
Naloxone Substudy: Worcester, MA; Characterizing Knowledge, Attitudes, Behaviors, and Practices Related to Bystander Naloxone (2019)Jeffrey T. Lai, MD, Charlotte Goldfine, MD, Brittany P. Chapman, BSc, Melissa M. Taylor, BA, Rochelle K. Rosen, Ph.D., Stephanie P. Carreiro, MD, and Kavita M. Babu, MD NDEWS-Naloxone-Report-Worcester FINAL.pdf73.33 KB
NDEWS Naloxone Substudy: Baltimore, Maryland; Characterizing Knowledge, Attitudes, Behaviors, and Practices Related to Bystander Naloxone (2019)Annabelle M. Belcher, Ph.D., Thomas O. Cole, MA, Alexander Pappas, MD, Raman Sandhu, MD, Rachel Steere, DO, and Zofia Kozak, BS NDEWS-Naloxone-Report-Baltimore-FINAL2.pdf956.5 KB
NDEWS Naloxone Substudy: Cleveland, Ohio (2019)Lee Hoffer, Ph.D., MPE, Allison Schlosser, Ph.D., MSW, and Kayla Buckelew NDEWS-Naloxone-Report-Cleveland-FINAL.pdf368.17 KB
Using Hospital Electronic Health Records to Monitor Drug Use Trends in Emergency Department PatientsBradford Schwartz, MD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA EDDS-EHR-MD-PrinceGeorges-UMPGHC-May2019.pdf618.18 KB
Using Hospital Electronic Health Records to Monitor Drug Use Trends in Emergency Department Patients at the University of Maryland Prince George’s Hospital CenterBradford Schwartz, MD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA Cerner_Bulletin_May2019_0.pdf621.93 KB
DEA Emerging Threat Report: First Quarter 2019Drug Enforcement Administration (DEA) Special Testing and Research Laboratory
DEWS Methodology OverviewBilling, A.S., Artigiani, E.E., Hippolyte, T., and Wish, E.D. (2019). Drug Early Warning Signals (DEWS): Methodology Overview. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Methodology-Overview-March-2019.pdf1.37 MB
Drug Early Warning Signals (DEWS): Operation PAR – North Fort Myers, Florida.Wish, E.D., Billing, A.S., Artigiani, E.E, and Hippolyte, T. (2019). Drug Early Warning Signals (DEWS): Operation PAR – North Fort Myers, Florida. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Operation-PAR-March-2019-Final.pdf1.02 MB
Drug Early Warning Signals (DEWS): Serenity Lane - Coburg, OregonBilling, A.S., Artigiani, E.E, Hippolyte, T., and Wish, E.D. (2019). Drug Early Warning Signals (DEWS): Serenity Lane - Coburg, Oregon. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Serenity-Lane-March-2019-Final.pdf1.06 MB
Using Electronic Health Records to Track Emerging Drug Problems in Baltimore (February 2019)Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA MPower_EpicBulletin_Feb2019_Revised_0.pdf443.65 KB
Using Hospital Electronic Health Records to Monitor Drug Use Trends in Overdose Patients (February 2019)Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA EDDS-EHR-MD-Baltimore-Feb2019.pdf443.61 KB
DEA Emerging Threat Report: Annual 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory DEA-Emerging-Threat-Report-2018-Annual.pdf404.56 KB
DEA Emerging Threat Report: Fourth Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory DEA-Emerging-Threat-Report-2018-Quarter-4.pdf270.34 KB
DOTS Issue 8 - Methamphetamine and New Psychoactive Substances Detected in Specimens from Pretrial Services Agency for the District of Columbia dotsbulletin-issue8-october2018-dcpsa_0.pdf148.3 KB
DEA Emerging Threat Report: Third Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-quarter-3.pdf159.93 KB
Methamphetamine: A Regional Drug Crisis (2018)NDEWS Sentinel Community Epidemiologists ndews-scs-methamphetamine-report-september-2018-final_0.pdf1.16 MB
DOTS Issue 7 - Methamphetamine, but No Fentanyl, Found in Opiate-Positive Specimens from a Corpus Christi, Texas, Residential Treatment Center; Multiple Drugs Found in Every Specimen dotsbulletin-issue7-august2018-charliesplacetx-final_0.pdf299.55 KB
CDEWS Reports: Drug Early Warning from Re-Testing Biological Samples: Allen County, Indiana. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. Wish, E.D., Billing, A.S., and Artigiani, E.E. (2018) finalreport_cdews4_inv36.pdf1.82 MB
CDEWS Reports: Drug Early Warning from Re-Testing Biological Samples: Jefferson/Lincoln/Pulaski/Rockcastle Counties, Kentucky. Office of National Drug Control Policy. Washington, DC: Executive Office of the President.Wish, E.D., Billing, A.S., and Artigiani, E.E. (2018). finalreport_cdews4_kyv43.pdf1.93 MB